{
    "clinical_study": {
        "@rank": "75401", 
        "arm_group": [
            {
                "arm_group_label": "Clomiphene Citrate Fast-Track Protocol", 
                "arm_group_type": "Experimental", 
                "description": "Subjects randomized to this group will be managed using the Clomiphene Citrate (Clomid) fast-track protocol and will receive Clomid without using Progestin throughout their treatment course.\nClomid 50 mg oral for 5 days (Day 3-7)\nIf no ovulation, Clomid 100 mg for 5 days (Day 12-16)\nIf no ovulation, Clomid 150 mg for 5 days (Day 21-25)"
            }, 
            {
                "arm_group_label": "Traditional Clomiphene Citrate Protocol", 
                "arm_group_type": "Active Comparator", 
                "description": "Women randomized to this group will receive Clomiphene Citrate (Clomid) using a traditional incremental-dose protocol, with Progestin given to induce a withdrawal bleed before starting any doses of Clomid.\nProgestin 10 mg oral for 10 days to induce a withdrawal bleed\nClomid 50 mg oral for 5 days (Day 3-7)\nIf no ovulation, Progestin 10 mg for 10 days to induce withdrawal bleed (Day 21-30) and Clomid 100 mg for 5 days (Day 36-40)\nIf no ovulation, Progestin 10 mg for 10 days to induce withdrawal bleed (Day 54-63) and Clomid 150 mg for 5 days (Day 69-73)"
            }
        ], 
        "brief_summary": {
            "textblock": "Women with polycystic ovary syndrome (PCOS) have traditionally been treated for infertility\n      by using progestin for a withdrawal bleed (aka endometrial shedding) before clomiphene\n      citrate (CC) is administered to induce ovulation.\n\n      Recent evidence suggests that this approach (the traditional CC protocol) may be associated\n      with decreased pregnancy and live birth rates, compared to the \"fast track\" CC protocol (in\n      which no progestin is used).\n\n      The investigators are performing the first randomized controlled trial to find out if\n      skipping the use of progestin (fast track CC protocol) during fertility therapy of\n      anovulatory PCOS women leads to improved pregnancy and live birth rates compared to the\n      traditional CC protocol."
        }, 
        "brief_title": "Clomiphene Citrate Fast-Track Protocol for Fertility Treatment in Women With PCOS", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Polycystic Ovary Syndrome", 
            "Infertility"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Polycystic Ovary Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion\n\n          -  Women ages 18 - 35, desiring pregnancy\n\n          -  Established diagnosis of PCOS confirmed by the Rotterdam criteria\n\n          -  Oligo or anovulatory, with menstrual cycles > 35 days apart or less than 9 menstrual\n             cycles per year\n\n          -  Normal vaginal ultrasound with endometrial stripe < 12mm\n\n          -  Normal thyroid stimulating hormone (TSH) within past one year\n\n          -  Normal prolactin (PRL) within past one year\n\n          -  For women with previous successful Clomid treatment, a washout period of at least 6\n             months is required\n\n          -  Negative beta hcg within past one month\n\n          -  Negative progesterone within past one month\n\n        Exclusion\n\n          -  BMI > 40\n\n          -  Regular menstrual cycles occurring less than 35 days apart\n\n          -  Evidence of other infertility factors such as endometriosis, tubal factor or male\n             infertility\n\n          -  Prior unsuccessful Clomid ovulation cycles\n\n          -  Abnormal vaginal ultrasound findings such as endometrial polyps, submucous myomas,\n             synechiae\n\n          -  Uterine anomaly such as unicornuate or bicornuate uterus\n\n          -  Presence of hydrosalpinx\n\n          -  Evidence of active endocrinopathy\n\n          -  Abnormal TSH\n\n          -  Abnormal PRL\n\n          -  Partner with abnormal semen analysis (count < 15 million sperm /ml)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "178", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01718444", 
            "org_study_id": "12-006213"
        }, 
        "intervention": [
            {
                "arm_group_label": "Traditional Clomiphene Citrate Protocol", 
                "intervention_name": "Progestin", 
                "intervention_type": "Drug", 
                "other_name": "Provera"
            }, 
            {
                "arm_group_label": [
                    "Clomiphene Citrate Fast-Track Protocol", 
                    "Traditional Clomiphene Citrate Protocol"
                ], 
                "intervention_name": "Clomiphene Citrate", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Clomid", 
                    "Clomiphene citrate"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Clomiphene", 
                "Progestins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PCOS", 
            "Polycystic ovary syndrome", 
            "Infertility", 
            "Anovulation", 
            "Clomiphene citrate", 
            "Clomid", 
            "Progestin"
        ], 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "email": "lemens.maureen@mayo.edu", 
                "last_name": "Maureen A Lemens, RN", 
                "phone": "507-293-1487"
            }, 
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }, 
            "investigator": [
                {
                    "last_name": "Jani R Jensen, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Albert Asante, M.B.B.Ch.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimizing Fertility Treatment in Women With Polycystic Ovary Syndrome (PCOS) Using the Clomiphene Citrate Fast-Track Protocol: a Randomized Controlled Trial", 
        "overall_contact": {
            "email": "lemens.maureen@mayo.edu", 
            "last_name": "Maureen A Lemens, BSN", 
            "phone": "507-293-1487"
        }, 
        "overall_contact_backup": {
            "email": "asante.albert@mayo.edu", 
            "last_name": "Albert Asante, MD, MPH", 
            "phone": "507-284-4520"
        }, 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Jani Jensen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clinical pregnancy confirmed by pelvic ultrasound", 
            "safety_issue": "No", 
            "time_frame": "Within 3 weeks of a positive pregnancy test"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01718444"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Jani Jensen", 
            "investigator_title": "Assistant Professor of Obstetrics-Gynecology, Consultant in Reproductive Endocrinology and Infertility", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to first ovulation", 
                "safety_issue": "No", 
                "time_frame": "Within 3 months of start of CC"
            }, 
            {
                "measure": "Time to clinical pregnancy", 
                "safety_issue": "No", 
                "time_frame": "Within 6 months of start of CC"
            }, 
            {
                "measure": "Live birth", 
                "safety_issue": "No", 
                "time_frame": "Delivery after 24 weeks of pregnancy"
            }
        ], 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}